Initiator Pharma A/S
STO:INIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Initiator Pharma A/S
Total Liabilities
Initiator Pharma A/S
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Initiator Pharma A/S
STO:INIT
|
Total Liabilities
kr3.4m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Total Liabilities
kr7B
|
CAGR 3-Years
158%
|
CAGR 5-Years
84%
|
CAGR 10-Years
61%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Total Liabilities
kr1.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
|
Galecto Inc
NASDAQ:GLTO
|
Total Liabilities
$1.3m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Total Liabilities
€1.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
60%
|
CAGR 10-Years
63%
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Total Liabilities
kr2.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
12%
|
|
Initiator Pharma A/S
Glance View
Initiator Pharma A/S is a clinical-stage biotechnology company, which engages in the development of novel therapeutics within the field of mono-amine reuptake transporters targeting central nervous system (CNS)-disorders. The firm focuses on developing drugs for treatment of erectile dysfunction.
See Also
What is Initiator Pharma A/S's Total Liabilities?
Total Liabilities
1.1m
DKK
Based on the financial report for Dec 31, 2024, Initiator Pharma A/S's Total Liabilities amounts to 1.1m DKK.
What is Initiator Pharma A/S's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-7%
Over the last year, the Total Liabilities growth was -94%. The average annual Total Liabilities growth rates for Initiator Pharma A/S have been -62% over the past three years , -7% over the past five years .
